Date
- 2026 (1)
- 2025 (38)
- 2024 (86)
- 2023 (73)
- 2022 (59)
- 2021 (124)
- 2020 (107)
- 2019 (98)
- 2018 (95)
- 2017 (73)
- 2016 (12)
- 2015 (22)
- 2014 (19)
- 2013 (9)
- 2012 (8)
- 2011 (14)
- 2010 (27)
- 2009 (13)
- 2008 (5)
- 2007 (11)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (3)
- 2002 (10)
- 2001 (6)
- 2000 (20)
- 1999 (9)
- 1998 (12)
- 1997 (16)
- 1996 (8)
- 1995 (3)
- 1994 (31)
- 1993 (17)
- 1992 (5)
- 1991 (86)
Sponsor content
1140 result(s) found, displaying 841 to 850
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Etanercept (rch)
-
PREVENAR 13 pneumococcal polysaccharide conjugate vaccine 13 valent adsorbed 0.5 mL syringe (158450)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVENAR 13 pneumococcal polysaccharide conjugate vaccine 13 valent adsorbed 0.5 mL syringe. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GENOTROPIN 5mg GOQUICK somatropin (rbe) powder for injection with preserved diluent pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GENOTROPIN 5.3mg GOQUICK somatropin (rbe) powder for injection with preserved diluent pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOLU-CORTEF ACT-O-VIAL hydrocortisone (as sodium succinate) 100mg powder for injection and diluent in dual-chamber vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GENOTROPIN 12mg GOQUICK somatropin (rbe) powder for injection with preserved diluent pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOLU-CORTEF ACT-O-VIAL hydrocortisone (as sodium succinate) 250mg powder for injection and diluent dual-chamber vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUTENT sunitinib (as malate) 37.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SUTENT sunitinib (as malate) 37.5 mg capsule bottle.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Crizotinib